News from NORD

NCATS Unveils Toolkit for Patient-Focused Therapy Development

Publish date: May 7, 2018

 

The National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) has developed a new toolkit for the rare disease community to facilitate therapeutics research and development. Learn more about the toolkit here .

Recommended Reading

Think about breast cancer surveillance for transgender patients
MDedge Hematology and Oncology
Lenalidomide yields responses in a rare cutaneous lymphoma
MDedge Hematology and Oncology
MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Hematology and Oncology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Hematology and Oncology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Hematology and Oncology
RFPs Available for the Study of Three Rare Diseases
MDedge Hematology and Oncology
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
MDedge Hematology and Oncology
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
MDedge Hematology and Oncology
NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans
MDedge Hematology and Oncology
Running for Rare Team Participates in Boston Marathon to Raise Funds for Undiagnosed Patients
MDedge Hematology and Oncology